The pattern most people follow
Effects cluster around beginnings: the first doses, then each step up. They typically peak in the day or two after a dose and fade as your system adapts. In the large trials of approved products in this class, gastrointestinal effects were the most commonly reported and were mostly mild to moderate and transient. Individual results vary.
Why slowing digestion explains most of it
These medicines slow how quickly the stomach empties. That is part of how fullness lasts longer, and it is also why a large, fast, fatty meal feels punishing. The dose is not the only variable – meal size and speed matter enormously.
What tends to shorten the rough patch
Smaller meals, eaten slower, stopping at comfortable rather than full. Protein first. Fluid between meals rather than during. Less alcohol, less fried food, at least at the start.
Semaglutide acts on the GLP-1 receptor – the same signalling your gut uses after a meal.
What is not a waiting game
Severe or persistent abdominal pain, especially radiating to the back, repeated vomiting, inability to keep fluids down, signs of dehydration, or symptoms suggesting gallbladder trouble need prompt clinical attention – not another week of patience.
Tell your clinician the unglamorous details
How often, how bad, what you ate, which day after your dose. That is the information that lets a clinician adjust the plan intelligently. See the 30-second film answers for this medication.
Why side effects are mostly digestive, and mostly early
Because the receptors semaglutide acts on sit in the gut and the brainstem, the predictable effects are digestive: nausea, reflux, constipation, diarrhoea, and a feeling of fullness that arrives sooner than expected. According to FDA prescribing information for semaglutide products, gastrointestinal reactions are the most commonly reported adverse events, and they are dose-related for many people. The practical implication is that they tend to cluster around a dose change rather than persist indefinitely. Serious risks are listed separately in the label, including pancreatitis, gallbladder disease, and a boxed warning for thyroid C-cell tumours in rodents. Those are not common, but they are the reason the medication is prescription-only. Report severe or persistent abdominal pain, vomiting that stops you keeping fluids down, or vision changes to your clinician promptly rather than waiting for a scheduled check-in.
FDA has warned about dosing errors reported with compounded GLP-1 products.
How semaglutide works on the GLP-1 receptor
Semaglutide is a GLP-1 receptor agonist. GLP-1 is an incretin hormone your intestine releases after eating; it prompts insulin release when glucose is elevated, slows gastric emptying, and signals satiety in the hypothalamus. Semaglutide binds the same receptor, and structural modifications give it a long half-life, which is what makes once-weekly dosing possible for the injectable form. It acts on one receptor rather than two, which is the pharmacological difference from tirzepatide. According to the FDA prescribing information for semaglutide products, that mechanism is the basis of the approved indications. Oral semaglutide reaches the same receptor by a different route and carries strict dosing conditions as a result, which oral versus injectable semaglutide covers. Whether any form suits you is decided by a licensed clinician after an evaluation.
What compounded means, and what it does not
A compounded preparation is made by a licensed pharmacy for an individual patient on receipt of a valid prescription. Compounded drugs are not FDA-approved, and FDA does not review them for safety, effectiveness, or quality before they are marketed. That is a statement about regulatory pathway, not an accusation about any particular pharmacy, and it is why the distinction matters more than marketing language does. A compounded preparation is not a generic and not an equivalent of any FDA-approved brand product. Published clinical trials such as STEP-1 studied the branded product at studied doses; those findings should not be assumed to transfer. What compounded means unpacks the legal framework, and red flags when buying online covers how to tell a legitimate pharmacy from a grey-market seller.
What a titration schedule is actually for
Titration means starting at a dose below the one intended to be effective and stepping up on a schedule. It exists for tolerability, not caution for its own sake. Receptor signalling that arrives gradually gives the gut time to adapt, which is why the label sets minimum intervals between increases rather than leaving the pace open. Skipping ahead does not accelerate anything except side effects. Holding at a dose is a legitimate clinical decision, and so is stepping back down. If you want the lower end of that range as a deliberate plan rather than a waypoint, that is what microdosing describes. Your clinician sets the schedule, reviews how you are tolerating it, and adjusts. Nothing about a titration plan guarantees a particular result, and no schedule substitutes for the follow-up conversation that decides whether to continue.
No card needed to see it. No insurance accepted or required.
Frequently asked questions
Do side effects come back at every dose increase?
Often mildly, and usually briefly. That is one reason titration exists – the schedule on your label is designed around it.
Can I take something for nausea?
Ask your clinician before adding anything, including over-the-counter products, so nothing interacts with your plan.
How do I inject semaglutide?
Follow the instructions supplied with your specific preparation. Weekly peptide injections are generally subcutaneous, into the abdomen away from the navel, the outer thigh, or the back of the upper arm, rotating the site each week. Contact the pharmacy before injecting if anything about your dose or volume is unclear.
Where do you inject semaglutide?
Subcutaneous sites are the abdomen, outer thigh, and back of the upper arm. Rotating between them reduces local irritation. Your dispensing pharmacy provides site guidance for your preparation.
How long do semaglutide side effects last?
Gastrointestinal effects are dose-related for many people, so they commonly cluster around a dose change and settle as the body adapts. Persistent or severe symptoms are a reason to contact your clinician rather than wait.
Is Wegovy the same as Ozempic?
Both contain semaglutide, but they are separate FDA-approved products with different approved indications and dosing. Neither is the same as a compounded semaglutide preparation, which is not FDA-approved.
The rough weeks are not the whole story
Get a plan built around how your body is actually responding. Rx only, refunded if you are not prescribed.
Rx only. A licensed clinician decides whether treatment is appropriate and may determine that no treatment, or a different treatment, is right for you. Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness, or quality before marketing. Individual results vary.
Sources
Clinical trials listed below evaluated FDA-approved products at the doses studied. They are cited as published science, not as evidence about any compounded preparation, which is not FDA-approved and has not been evaluated by FDA for safety, effectiveness, or quality.
- Peer-reviewedWilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity (STEP 1). N Engl J Med 2021;384:989-1002
- FDAFDA: Alerts health care providers, compounders and patients of dosing errors associated with compounded semaglutide injectable products
- FDA databaseDrugs@FDA: search approved labeling for semaglutide
- Peer-reviewedSTEP-1: Once-Weekly Semaglutide in Adults with Overweight or Obesity (NEJM 2021)
Spotted something inaccurate? Report an error – corrections are logged per our editorial standards.
More on Compounded Semaglutide
Same medication, different question.
